Australia short of 3 million AstraZeneca COVID-19 vaccine doses in blow to vaccination drive | Inquirer News

Australia short of 3 million AstraZeneca COVID-19 vaccine doses in blow to vaccination drive

/ 05:17 PM April 06, 2021

SYDNEY — Australia on Tuesday said it had not yet received more than 3 million doses of previously promised AstraZeneca COVID-19 vaccine doses amid export curbs by the European Union, leaving a major hole in its early nationwide inoculation drive.

Authorities had pledged to administer at least 4 million first doses of the vaccine by end-March, but could only vaccinate 670,000 after the European Union blocked AstraZeneca vaccine exports to Australia in the wake of the drugmaker’s failure to meet its shipment pledge to the bloc.

“We were scheduled to have received over 3 million doses of the AstraZeneca vaccine from overseas by now, which have not arrived in Australia because of the problems with shipments that we’ve seen happening here and in other parts of the world,” Acting Chief Medical Officer Michael Kidd told Sky News.

Article continues after this advertisement

Australia began vaccinations much later than some other countries due to low case numbers, recording just under 29,400 COVID-19 cases and 909 deaths since the pandemic began. But the AstraZeneca dose delay leaves it struggling to step up the pace of its vaccination drive.

FEATURED STORIES

The majority of Australia’s near 26 million population will be administered the AstraZeneca vaccine, with 50 million doses set to be produced locally from the end of March. About 2.5 million doses have been locally produced so far with thousands of doses already cleared testing and distributed to the vaccination sites.

The Pharmacy Guild of Australia, tasked to help with the rollout of the nationwide inoculation program from May, said on Tuesday that slow domestic vaccine approvals and logistics issues will now push deliveries to June.

Article continues after this advertisement

“We have been told that the delay is linked to supply chain delays rather than the ability of the pharmacy network to participate,” Pharmacy Guild President Trent Twomey told Reuters.

Article continues after this advertisement

Twomey also blamed the slow rollout on a lack of coordination between the Australian national government and states, with the latter complaining about slower-than-expected distribution and a lack of certainty on vaccine supplies.

National authorities, however, said vaccination centers would be doubled by the end of the week, as they look to ramp up the vaccination program that aims to provide at least one dose to every person by the end of October.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, Australia, COVID-19, COVID-19 Vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.